Deepti Jain
CIK: 0001840203
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TMCI
TREACE MEDICAL CONCEPTS, INC.
Director
Discretionary Trading P&L
Holdings
About Jain Deepti
Jain Deepti (SEC CIK 0001840203) files insider reports with the SEC as Director of TREACE MEDICAL CONCEPTS, INC. (TMCI).
Signal8 holds 2 ownership filings by Jain Deepti, all Form 4s, filed between May 21, 2025 and May 19, 2026. Those filings report 2 transactions, from May 20, 2025 to May 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Jain Deepti's filings is in PONTE VEDRA, FL.
Recent filings by Jain Deepti
Other insiders filing for TREACE MEDICAL CONCEPTS, INC. (TMCI)
- Scanlan Sean F., Chief Innovation Officer
- Elder Scot Michael, Chief Legl & Comp Off, CorpSec
- Treace John T., Chief Executive Officer
- Hair Mark, Chief Financial Officer
- BAKEWELL JOHN K, Director
- Kiernan Jane E, Director